000 01601 a2200433 4500
005 20250513143202.0
264 0 _c19980528
008 199805s 0 0 eng d
022 _a0022-3050
024 7 _a10.1136/jnnp.64.5.573
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aColzi, A
245 0 0 _aContinuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease.
_h[electronic resource]
260 _bJournal of neurology, neurosurgery, and psychiatry
_cMay 1998
300 _a573-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntiparkinson Agents
_xadministration & dosage
650 0 4 _aApomorphine
_xadministration & dosage
650 0 4 _aChronotherapy
650 0 4 _aDopamine Agonists
_xadministration & dosage
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aDyskinesia, Drug-Induced
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusion Pumps, Implantable
650 0 4 _aInjections, Subcutaneous
650 0 4 _aLevodopa
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeurologic Examination
_xdrug effects
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aTreatment Outcome
700 1 _aTurner, K
700 1 _aLees, A J
773 0 _tJournal of neurology, neurosurgery, and psychiatry
_gvol. 64
_gno. 5
_gp. 573-6
856 4 0 _uhttps://doi.org/10.1136/jnnp.64.5.573
_zAvailable from publisher's website
999 _c9565399
_d9565399